Muhammet Hamidullah UYANIK, Kemalettin ÖZDEN, Serpil EROL, Zülal ÖZKURT, Mehmet PARLAK

Cutaneous anthrax patients in Eastern Anatolia, Turkey: a review of 44 adults cases

Anthrax is a zoonotic infectious disease caused by B. anthracis. It remains as an important issue in developing countries and it is a potential threat for the world because of its use as a biological weapon. In this study, we evaluated the epidemiological, clinical, and laboratory characteristics of 44 patients with cutaneous anthrax in our region. Materials and methods: The study included 44 cutaneous anthrax patients admitted to our hospital from the Eastern Anatolia Region of Turkey between 2005 and 2008. Results: Out of 44 cases, 24 (54.5%) were male and 20 (45.5%) female. The mean age was 41 ± 14.96 years. High risk occupations were farmers (n = 21, 48%) and housewives (n = 19, 43%). The sample consisted of 33 (75%) cutaneous anthrax with pustular lesion and 11 (25%) severe cutaneous anthrax with extensive edema. The most common exposures to sick animal or animal products were cutting of meat (n = 36, 81.8%), slaughtering of animal (n = 34, 77.3%), and direct contact with sick animal (n = 22, 50%). Cutaneous lesions were commonly located on hands (n = 24, 54.5%), arms (18, 40.9%), and fingers (n = 11, 25%). No death occurred and all of them were discharged from hospital. Conclusion: Anthrax is still an important health issue in Turkey and usually presents as a cutaneous anthrax. Cutaneous anthrax should be considered in any patient with a painless ulcer with vesicles, edema, and a history of exposure to animals or animal products. The people under risk should be informed about risky exposures. Vaccination of animals may decrease the number of animal and human anthrax cases.

Anahtar Kelimeler:

Key words: Bacillus anthracis, anthrax, cutaneous anthrax

Cutaneous anthrax patients in Eastern Anatolia, Turkey: a review of 44 adults cases

Keywords:

Key words: Bacillus anthracis, anthrax, cutaneous anthrax,

PDF

___

Irmak H, Buzgan T, Karahocagil MK, Sakarya N, Akdeniz H, Caksen H et al. Cutaneous manifestations of anthrax in eastern Anatolia: a review of 39 cases. Acta Med Okayama 2003; 57: 235-40.
Ozcan H, Kayabas U, Bayindir Y, Bayraktar MR, Ay S. Evaluation of 23 cutaneous anthrax patients in eastern Anatolia, Turkey: diagnosis and risk factors. Int J Dermatol. 2008 Oct; 47: 1033-7.
Kaya A, Tasyaran MA, Erol S, Ozkurt Z, Ozkan B. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002; 21: 258-61.
Sternbach G. Th e history of anthrax. J EmergMed 2003; 24: 463-7.
Engin A, Elaldi N, Dokmetas I, Bakici MZ, Kaya S, Bakir M. Cutaneous Anthrax in the Central Anatolia Region of Turkey: A Review of 39 Adults Cases. Turkiye Klinikleri J Med Sci 2010; 30: 1032-8.
Karahocagil MK, Akdeniz N, Akdeniz H, Calka O, Karsen H, Bilici A et al. Cutaneous anthrax in Eastern Turkey: a review of 85 cases. Clin Exp Dermatol. 2008l; 33: 406-11.
Doganay M, Kökkaya A, Hah MM. 35 şarbon olgusunun değerlendirimi. Microbiol Bült 1983; 17: 1-10.
Oncül O, Ozsoy MF, Gul HC, Koçak N, Cavuslu S, Pahsa A. Cutaneous anthrax in Turkey: a review of 32 cases. Scand J Infect Dis 2002;34(6):413-6.
Baykam N, Ergonul O, Ulu A, Eren S, Celikbas A, Eroglu M et al. Characteristics of cutaneous anthrax in Turkey. J Infect Dev Ctries. 2009; 3: 599-603.
Demirdag K, Ozden M, Saral Y, Kalkan A, Kilic SS, Ozdarendeli A. Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey. Infection 2003; 31: 327-30.
Hugh-Jones ME, deVos V. Anthrax and wildlife. Rev Sci Tech 2002; 21: 359-383.
Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287: 2236-52.
Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A et al. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax. Euro Surveill 2004; 9: E3-4.
Stern EJ, Uhde KB, Shadomy SV, Messonnier N. Conference report on public health and clinical guidelines for anthrax. Emerg Infect Dis. 2008; 14. pii: 07-0969.
Waterer GW, Robertson H. Bioterrorism for the respiratory physician. Respirology 2009; 14: 5-11.
Lalitha MK, Th omas MK. Penicillin resistancein Bacillus anthracis. Lancet 1997; 349: 1522.
Metan G, Doğanay M. Th e antimicrobial susceptibility of Bacillus anthracis isolated from human cases: A review of the Turkish Literature. Turkiye Klinikleri J Med Sci 2009; 29: 229- 35.